| Year |
Citation |
Score |
| 2023 |
Barker D, Han X, Wang E, Dagley A, Anderson DM, Jha A, Weaver SC, Julander J, Nykiforuk C, Kodihalli S. Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in Mice. Viruses. 15. PMID 37515166 DOI: 10.3390/v15071479 |
0.538 |
|
| 2023 |
Tillis SB, Holt C, Havens S, Logan TD, Julander JG, Ossiboff RJ. In Vitro Characterization and Antiviral Susceptibility of Ophidian Serpentoviruses. Microorganisms. 11. PMID 37374873 DOI: 10.3390/microorganisms11061371 |
0.402 |
|
| 2023 |
Sparrow KJ, Shrestha R, Wood JM, Clinch K, Hurst BL, Wang H, Gowen BB, Julander JG, Tarbet EB, McSweeney AM, Ward VK, Evans GB, Harris LD. An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the Order. Acs Medicinal Chemistry Letters. 14: 506-513. PMID 37077387 DOI: 10.1021/acsmedchemlett.3c00048 |
0.346 |
|
| 2023 |
Cao X, Yang D, Parvathareddy J, Chu YK, Kim EJ, Fitz-Henley JN, Li X, Lukka PB, Parmar KR, Temrikar ZH, Dhole P, Adcock RS, Gabbard J, Bansal S, Lee J, ... ... Julander JG, et al. Efficacy of a brain-penetrant antiviral in lethal Venezuelan and eastern equine encephalitis mouse models. Science Translational Medicine. 15: eabl9344. PMID 37043558 DOI: 10.1126/scitranslmed.abl9344 |
0.432 |
|
| 2023 |
Ricciardi MJ, Rust LN, Pedreño-Lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, DiBello JR, Raué HP, Barber-Axthelm AM, Chun K, Uttke S, ... ... Julander JG, et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science Translational Medicine. 15: eade5795. PMID 36989376 DOI: 10.1126/scitranslmed.ade5795 |
0.39 |
|
| 2022 |
Julander JG, Bunyan E, Jordan R, Porter DP. Remdesivir efficacy against yellow fever in a hamster model. Antiviral Research. 105331. PMID 35533777 DOI: 10.1016/j.antiviral.2022.105331 |
0.496 |
|
| 2022 |
Doyle MP, Genualdi JR, Bailey AL, Kose N, Gainza C, Rodriguez J, Reeder KM, Nelson CA, Jethva PN, Sutton RE, Bombardi RG, Gross ML, Julander JG, Fremont DH, Diamond MS, et al. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus. Mbio. e0051222. PMID 35420472 DOI: 10.1128/mbio.00512-22 |
0.408 |
|
| 2022 |
Julander JG, Anderson N, Haese N, Andoh T, Streblow DN, Cortez P, Carter K, Marniquet X, Watson H, Mandron M. Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease. Antiviral Research. 105295. PMID 35339583 DOI: 10.1016/j.antiviral.2022.105295 |
0.511 |
|
| 2022 |
Lin K, Good SS, Julander JG, Weight AE, Moussa A, Sommadossi JP. AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model. Plos Neglected Tropical Diseases. 16: e0009937. PMID 35073319 DOI: 10.1371/journal.pntd.0009937 |
0.523 |
|
| 2021 |
Julander JG, Demarest JF, Taylor R, Gowen BB, Walling DM, Mathis A, Babu YS. An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Research. 195: 105180. PMID 34551346 DOI: 10.1016/j.antiviral.2021.105180 |
0.397 |
|
| 2021 |
Good SS, Shannon A, Lin K, Moussa A, Julander JG, La Colla P, Collu G, Canard B, Sommadossi JP. Evaluation of AT-752, a double prodrug of a guanosine nucleotide analog with and activity against dengue and other flaviviruses. Antimicrobial Agents and Chemotherapy. AAC0098821. PMID 34424050 DOI: 10.1128/AAC.00988-21 |
0.478 |
|
| 2021 |
Williamson LE, Reeder KM, Bailey K, Tran MH, Roy V, Fouch ME, Kose N, Trivette A, Nargi RS, Winkler ES, Kim AS, Gainza C, Rodriguez J, Armstrong E, Sutton RE, ... ... Julander JG, et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 184: 4430-4446.e22. PMID 34416147 DOI: 10.1016/j.cell.2021.07.033 |
0.325 |
|
| 2021 |
Vang L, Morello CS, Mendy J, Thompson D, Manayani D, Guenther B, Julander J, Sanford D, Jain A, Patel A, Shabram P, Smith J, Alexander J. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus. Plos Neglected Tropical Diseases. 15: e0009195. PMID 33711018 DOI: 10.1371/journal.pntd.0009195 |
0.411 |
|
| 2020 |
Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, Fuchs J, Ruzsics Z, Überla K, Jäck HM, Ptak R, Muehler A, Gröppel M, Vitt D, et al. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Viruses. 12. PMID 33291455 DOI: 10.3390/v12121394 |
0.348 |
|
| 2020 |
Julander JG, Dagley A, Gebre M, Komeno T, Nakajima N, Smee DF, Furuta Y. Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus. Antiviral Research. 182: 104904. PMID 32791074 DOI: 10.1016/J.Antiviral.2020.104904 |
0.595 |
|
| 2020 |
Liang B, Yuan X, Wei G, Wang W, Zhang M, Peng H, Javer A, Mendenhall M, Julander J, Huang S, Michail H, Lu Y, Zhu Q, Baldwin J. Toxicity Studies and Inactivation of SARS-CoV-2 by Povidone-iodine Gel Forming Formulations. Biorxiv : the Preprint Server For Biology. PMID 32511395 DOI: 10.1101/2020.05.18.103184 |
0.376 |
|
| 2020 |
Yun SI, Song BH, Woolley ME, Frank JC, Julander JG, Lee YM. Development, Characterization, and Application of Two Reporter-Expressing Recombinant Zika Viruses. Viruses. 12. PMID 32456014 DOI: 10.3390/V12050572 |
0.457 |
|
| 2020 |
Zarai Y, Zafrir Z, Siridechadilok B, Suphatrakul A, Ruppin M, Julander J, Tuller T. Evolutionary Selection against Short Nucleotide Sequences in Viruses and their Related Hosts. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. PMID 32339222 DOI: 10.1093/Dnares/Dsaa008 |
0.408 |
|
| 2020 |
Quintana VM, Selisko B, Brunetti JE, Eydoux C, Guillemot JC, Canard B, Damonte EB, Julander JG, Castilla V. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses. Antiviral Research. 176: 104749. PMID 32081740 DOI: 10.1016/J.Antiviral.2020.104749 |
0.513 |
|
| 2019 |
Clancy CS, Van Wettere AJ, Morrey JD, Julander JG. Zika Virus Associated Pathology and Antigen Presence in the Testicle in the Absence of Sexual Transmission During Subacute to Chronic Infection in a Mouse Model. Scientific Reports. 9: 8325. PMID 31171800 DOI: 10.1038/S41598-019-44582-9 |
0.686 |
|
| 2019 |
Jonsson CB, Cao X, Lee J, Gabbard JD, Chu YK, Fitzpatrick EA, Julander J, Chung DH, Stabenow J, Golden JE. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses. Antiviral Research. PMID 30970271 DOI: 10.1016/J.Antiviral.2019.04.004 |
0.528 |
|
| 2019 |
Siddharthan V, Miao J, Van Wettere AJ, Li R, Wu H, Sullivan E, Jiao J, Hooper JW, Safronetz D, Morrey JD, Julander JG, Wang Z. Human Polyclonal Antibodies Produced from Transchromosomal Bovine Provides Prophylactic and Therapeutic Protections Against Zika Virus Infection in KO Syrian Hamsters. Viruses. 11. PMID 30678320 DOI: 10.3390/V11020092 |
0.694 |
|
| 2018 |
Clancy CS, Van Wettere AJ, Morrey JD, Julander JG. Coitus-Free Sexual Transmission of Zika Virus in a Mouse Model. Scientific Reports. 8: 15379. PMID 30337585 DOI: 10.1038/S41598-018-33528-2 |
0.673 |
|
| 2018 |
Julander JG, Testori M, Cheminay C, Volkmann A. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model. Frontiers in Immunology. 9: 1756. PMID 30116244 DOI: 10.3389/Fimmu.2018.01756 |
0.354 |
|
| 2018 |
Yun SI, Song BH, Frank JC, Julander JG, Olsen AL, Polejaeva IA, Davies CJ, White KL, Lee YM. Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection. Viruses. 10. PMID 30103523 DOI: 10.3390/V10080422 |
0.491 |
|
| 2018 |
Julander JG, Siddharthan V, Park AH, Preston E, Mathur P, Bertolio M, Wang H, Zukor K, Van Wettere AJ, Sinex DG, Morrey JD. Consequences of in utero exposure to Zika virus in offspring of AG129 mice. Scientific Reports. 8: 9384. PMID 29925850 DOI: 10.1038/S41598-018-27611-X |
0.705 |
|
| 2018 |
Goz E, Tsalenchuck Y, Benaroya RO, Zafrir Z, Atar S, Altman T, Julander J, Tuller T. Generation and comparative genomics of synthetic dengue viruses. Bmc Bioinformatics. 19: 140. PMID 29745863 DOI: 10.1186/S12859-018-2132-3 |
0.45 |
|
| 2018 |
Magnani DM, Rogers TF, Maness NJ, Grubaugh ND, Beutler N, Bailey VK, Gonzalez-Nieto L, Gutman MJ, Pedreño-Lopez N, Kwal JM, Ricciardi MJ, Myers TA, Julander JG, Bohm RP, Gilbert MH, et al. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. Nature Communications. 9: 1624. PMID 29691387 DOI: 10.1038/S41467-018-04056-4 |
0.549 |
|
| 2018 |
Zukor K, Wang H, Siddharthan V, Julander JG, Morrey JD. Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice. Journal of Neurovirology. PMID 29476408 DOI: 10.1007/S13365-017-0595-Z |
0.606 |
|
| 2018 |
Clancy CS, Van Wettere AJ, Siddharthan V, Morrey JD, Julander JG. Comparative Histopathologic Lesions of the Male Reproductive Tract during Acute Infection of Zika Virus in AG129 and IFNAR-/- Mice. The American Journal of Pathology. PMID 29378173 DOI: 10.1016/J.Ajpath.2017.12.019 |
0.692 |
|
| 2017 |
Julander JG, Siddharthan V. Small-Animal Models of Zika Virus. The Journal of Infectious Diseases. 216: S919-S927. PMID 29267919 DOI: 10.1093/Infdis/Jix465 |
0.57 |
|
| 2017 |
Siddharthan V, Van Wettere AJ, Li R, Miao J, Wang Z, Morrey JD, Julander JG. Zika virus infection of adult and fetal STAT2 knock-out hamsters. Virology. 507: 89-95. PMID 28431283 DOI: 10.1016/J.Virol.2017.04.013 |
0.705 |
|
| 2017 |
Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 169: 176. PMID 28340344 DOI: 10.1016/J.Cell.2017.03.016 |
0.461 |
|
| 2017 |
Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. PMID 28222903 DOI: 10.1016/J.Cell.2017.02.017 |
0.441 |
|
| 2016 |
Julander JG, Siddharthan V, Evans J, Taylor R, Tolbert K, Apuli C, Stewart J, Collins P, Gebre M, Neilson S, Van Wettere A, Lee YM, Sheridan WP, Morrey JD, Babu YS. Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antiviral Research. PMID 27838352 DOI: 10.1016/J.Antiviral.2016.11.003 |
0.755 |
|
| 2016 |
Guo F, Wu S, Julander J, Ma J, Zhang X, Kulp J, Cuconati A, Block TM, Du Y, Guo JT, Chang J. A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein. Journal of Virology. PMID 27654301 DOI: 10.1128/Jvi.01253-16 |
0.534 |
|
| 2016 |
Yun SI, Song BH, Frank JC, Julander JG, Polejaeva IA, Davies CJ, White KL, Lee YM. Complete Genome Sequences of Three Historically Important, Spatiotemporally Distinct, and Genetically Divergent Strains of Zika Virus: MR-766, P6-740, and PRVABC-59. Genome Announcements. 4. PMID 27540058 DOI: 10.1128/Genomea.00800-16 |
0.308 |
|
| 2016 |
Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J, Dobo S, Rose A, El-Kattan Y, Taubenheim B, Babu Y, Sheridan WP. BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease. Journal of Infection and Public Health. PMID 27095300 DOI: 10.1016/J.Jiph.2016.04.002 |
0.595 |
|
| 2016 |
Julander JG. Animal models of yellow fever and their application in clinical research. Current Opinion in Virology. 18: 64-69. PMID 27093699 DOI: 10.1016/J.Coviro.2016.03.010 |
0.569 |
|
| 2014 |
Julander JG, Bantia S, Taubenheim BR, Minning DM, Kotian P, Morrey JD, Smee DF, Sheridan WP, Babu YS. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model. Antimicrobial Agents and Chemotherapy. 58: 6607-14. PMID 25155605 DOI: 10.1128/Aac.03368-14 |
0.666 |
|
| 2014 |
Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, ... Julander JG, et al. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. Plos Pathogens. 10: e1004213. PMID 24967809 DOI: 10.1371/Journal.Ppat.1004213 |
0.464 |
|
| 2014 |
Julander JG, Kesler K, Van Wettere AJ, Morrey JD, Smee DF. The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection. Antiviral Research. 108: 10-3. PMID 24837607 DOI: 10.1016/J.Antiviral.2014.05.002 |
0.696 |
|
| 2014 |
Dagley A, Ennis J, Turner JD, Rood KA, Van Wettere AJ, Gowen BB, Julander JG. Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Research. 108: 1-9. PMID 24833276 DOI: 10.1016/J.Antiviral.2014.05.004 |
0.616 |
|
| 2014 |
Julander JG, Thibodeaux BA, Morrey JD, Roehrig JT, Blair CD. Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model. Antiviral Research. 103: 32-8. PMID 24393669 DOI: 10.1016/J.Antiviral.2013.12.011 |
0.699 |
|
| 2014 |
Wu CC, Crain B, Yao S, Sabet M, Lao FS, Tawatao RI, Chan M, Smee DF, Julander JG, Cottam HB, Guiney DG, Corr M, Carson DA, Hayashi T. Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand. Journal of Innate Immunity. 6: 315-24. PMID 24192551 DOI: 10.1159/000355217 |
0.373 |
|
| 2013 |
Dagley A, Julander JG. A mouse model of chikungunya virus with utility in antiviral studies. Methods in Molecular Biology (Clifton, N.J.). 1030: 439-48. PMID 23821287 DOI: 10.1007/978-1-62703-484-5_33 |
0.561 |
|
| 2013 |
Wang H, Siddharthan V, Kesler KK, Hall JO, Motter NE, Julander JG, Morrey JD. Fatal neurological respiratory insufficiency is common among viral encephalitides. The Journal of Infectious Diseases. 208: 573-83. PMID 23641019 DOI: 10.1093/Infdis/Jit186 |
0.691 |
|
| 2013 |
Julander JG. Experimental therapies for yellow fever. Antiviral Research. 97: 169-79. PMID 23237991 DOI: 10.1016/J.Antiviral.2012.12.002 |
0.523 |
|
| 2013 |
Taylor JS, Zhang Q, Julander JG, Stoycheva AD, Tan H, Moy CV, Chanda S, Symons JA, Beigelman LN, Blatt LM, Hong J. 257 Cytokine. 63: 304. DOI: 10.1016/J.Cyto.2013.06.260 |
0.373 |
|
| 2012 |
Smee DF, Julander JG, Tarbet EB, Gross M, Nguyen J. Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents. Antiviral Research. 96: 13-20. PMID 22809862 DOI: 10.1016/J.Antiviral.2012.07.002 |
0.526 |
|
| 2012 |
Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. Plos One. 7: e31006. PMID 22292088 DOI: 10.1371/Journal.Pone.0031006 |
0.503 |
|
| 2011 |
Zasloff M, Adams AP, Beckerman B, Campbell A, Han Z, Luijten E, Meza I, Julander J, Mishra A, Qu W, Taylor JM, Weaver SC, Wong GC. Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proceedings of the National Academy of Sciences of the United States of America. 108: 15978-83. PMID 21930925 DOI: 10.1073/Pnas.1108558108 |
0.402 |
|
| 2011 |
Julander JG, Hagloch J, Latimer S, Motter N, Dagley A, Barnard DL, Smee DF, Morrey JD. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. Antiviral Research. 92: 228-36. PMID 21867731 DOI: 10.1016/J.Antiviral.2011.08.011 |
0.697 |
|
| 2011 |
Julander JG, Trent DW, Monath TP. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model. Vaccine. 29: 6008-16. PMID 21718741 DOI: 10.1016/J.Vaccine.2011.06.034 |
0.356 |
|
| 2011 |
Julander JG, Ennis J, Turner J, Morrey JD. Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Antimicrobial Agents and Chemotherapy. 55: 2067-73. PMID 21300837 DOI: 10.1128/Aac.01635-10 |
0.751 |
|
| 2011 |
Julander JG, Perry ST, Shresta S. Important advances in the field of anti-dengue virus research. Antiviral Chemistry & Chemotherapy. 21: 105-16. PMID 21233532 DOI: 10.3851/Imp1690 |
0.508 |
|
| 2011 |
Julander JG, Ennis J, Morrey J, Turner J. Effective Prophylactic and Therapeutic Treatment of Yellow Fever Virus with an Adenovirus-vectored Interferon, DEF201, in a Hamster Model Antiviral Research. 90: A34. DOI: 10.1016/J.Antiviral.2011.03.040 |
0.706 |
|
| 2011 |
Smee DF, Wong M, Tarbet EB, Julander J, Gross M, Nguyen J. Activities of Viral M2 Channel, Neuraminidase, and RNA Polymerase Inhibitors on Oseltamivir-Resistant H275Y Influenza A (H1N1) Virus Infections in Mice Antiviral Research. 90: A27. DOI: 10.1016/J.Antiviral.2011.03.019 |
0.514 |
|
| 2010 |
Gowen BB, Julander JG, London NR, Wong MH, Larson D, Morrey JD, Li DY, Bray M. Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virology Journal. 7: 240. PMID 20846417 DOI: 10.1186/1743-422X-7-240 |
0.651 |
|
| 2010 |
Lam AM, Murakami E, Espiritu C, Steuer HM, Niu C, Keilman M, Bao H, Zennou V, Bourne N, Julander JG, Morrey JD, Smee DF, Frick DN, Heck JA, Wang P, et al. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrobial Agents and Chemotherapy. 54: 3187-96. PMID 20516278 DOI: 10.1128/Aac.00399-10 |
0.616 |
|
| 2010 |
Monath TP, Lee CK, Julander JG, Brown A, Beasley DW, Watts DM, Hayman E, Guertin P, Makowiecki J, Crowell J, Levesque P, Bowick GC, Morin M, Fowler E, Trent DW. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine. 28: 3827-40. PMID 20347059 DOI: 10.1016/J.Vaccine.2010.03.023 |
0.305 |
|
| 2010 |
Julander JG, Jha AK, Choi JA, Jung KH, Smee DF, Morrey JD, Chu CK. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model. Antiviral Research. 86: 261-7. PMID 20227442 DOI: 10.1016/J.Antiviral.2010.03.004 |
0.719 |
|
| 2010 |
Hong J, Taylor JS, Julander JG, Zhang Q, Stoycheva AD, Tan H, Moy CV, Chanda S, Beigelman LN, Blatt LM. PS2-39 Development of a hyperglycosylated IFN alfacon1 (CIFN): Towards once a month dosing for antiviral therapy Cytokine. 52: 58. DOI: 10.1016/J.Cyto.2010.07.244 |
0.312 |
|
| 2010 |
Julander J, Jha A, Choi J, Smee D, Morrey J, Chu C. Efficacy of 2′-C-Methylcytidine Against Yellow Fever Virus in a Hamster Model of Disease Antiviral Research. 86: A35-A36. DOI: 10.1016/J.Antiviral.2010.02.380 |
0.671 |
|
| 2009 |
Julander JG, Smee DF, Morrey JD, Furuta Y. Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Research. 82: 169-71. PMID 19428608 DOI: 10.1016/J.Antiviral.2009.02.201 |
0.721 |
|
| 2009 |
Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, Gowen BB, Julander JG, Morrey JD. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research. 82: 95-102. PMID 19428599 DOI: 10.1016/J.Antiviral.2009.02.198 |
0.727 |
|
| 2009 |
Nair V, Chi G, Shu Q, Julander J, Smee DF. A heterocyclic molecule with significant activity against dengue virus. Bioorganic & Medicinal Chemistry Letters. 19: 1425-7. PMID 19185487 DOI: 10.1016/J.Antiviral.2009.02.148 |
0.477 |
|
| 2009 |
Julander JG, Shafer K, Smee DF, Morrey JD, Furuta Y. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrobial Agents and Chemotherapy. 53: 202-9. PMID 18955536 DOI: 10.1128/Aac.01074-08 |
0.691 |
|
| 2009 |
Nair V, Chi G, Shu Q, Julander J, Smee D. A Heterocyclic Molecule with Significant Activity Against Dengue Virus Antiviral Research. 82: A62. DOI: 10.1016/j.antiviral.2009.02.148 |
0.377 |
|
| 2009 |
Julander J, Smee D, Morrey J, Furuta Y. Comparison of Various Combination Therapies for the Treatment of Yellow Fever Virus Antiviral Research. 82: A29. DOI: 10.1016/J.Antiviral.2009.02.049 |
0.672 |
|
| 2008 |
Julander JG, Bowen RA, Rao JR, Day C, Shafer K, Smee DF, Morrey JD, Chu CK. Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Research. 80: 309-15. PMID 18675850 DOI: 10.1016/J.Antiviral.2008.07.002 |
0.831 |
|
| 2008 |
Julander JG, Skirpstunas R, Siddharthan V, Shafer K, Hoopes JD, Smee DF, Morrey JD. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Research. 78: 230-41. PMID 18313150 DOI: 10.1016/J.Antiviral.2008.01.007 |
0.706 |
|
| 2008 |
Julander J, Shafer K, Smee D, Morrey J, Furuta Y. Efficacy of T-1106 or T-705, Alone or in Combination with Ribavirin, in the Treatment of Hamsters Infected with Yellow Fever Virus Antiviral Research. 78: A34. DOI: 10.1016/J.Antiviral.2008.01.060 |
0.666 |
|
| 2007 |
Selvam P, Vijayalakshimi P, Smee DF, Gowen BB, Julander JG, Day CW, Barnard DL. Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses. Antiviral Chemistry & Chemotherapy. 18: 301-5. PMID 18046963 DOI: 10.1177/095632020701800506 |
0.72 |
|
| 2007 |
Morrey JD, Siddharthan V, Olsen AL, Wang H, Julander JG, Hall JO, Li H, Nordstrom JL, Koenig S, Johnson S, Diamond MS. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Antimicrobial Agents and Chemotherapy. 51: 2396-402. PMID 17452485 DOI: 10.1128/Aac.00147-07 |
0.721 |
|
| 2007 |
Julander JG, Furuta Y, Shafer K, Sidwell RW. Activity of T-1106 in a hamster model of yellow Fever virus infection. Antimicrobial Agents and Chemotherapy. 51: 1962-6. PMID 17420215 DOI: 10.1128/Aac.01494-06 |
0.563 |
|
| 2007 |
Julander JG, Judge JW, Olsen AL, Rosenberg B, Schafer K, Sidwell RW. Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection. Antiviral Research. 75: 14-9. PMID 17210189 DOI: 10.1016/J.Antiviral.2006.11.005 |
0.551 |
|
| 2007 |
Julander JG, Siddharthan V, Blatt LM, Schafer K, Sidwell RW, Morrey JD. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology. 360: 454-60. PMID 17118420 DOI: 10.1016/J.Virol.2006.10.031 |
0.762 |
|
| 2007 |
Julander JG, Morrey JD, Blatt LM, Shafer K, Sidwell RW. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Research. 73: 140-6. PMID 17049380 DOI: 10.1016/J.Antiviral.2006.08.008 |
0.725 |
|
| 2007 |
RAO J, JULANDER J, SIDWELL R, CHU C. Practical Synthesis of (−)-Carbocyclic Cytosine (Carbodine) and its In Vitro Antiviral Activity against Venezuelan Equine Encephalitis (VEE) Virus and Yellow Fever Virus Antiviral Research. 74: A47-A47. DOI: 10.1016/J.Antiviral.2007.01.057 |
0.529 |
|
| 2007 |
OLSEN A, MORREY J, JULANDER J, HALL J, SKIRPSTUNAS R, SIDWELL R. Lymphocytic Necrosis in Hamsters Inoculated with Western Equine Encephalitis Virus Antiviral Research. 74: A46-A46. DOI: 10.1016/J.Antiviral.2007.01.053 |
0.72 |
|
| 2007 |
JULANDER J, CHU C, RAO J, SHAFER K, MORREY J. Antiviral Activity of (−)-Carbocyclic Cytosine [(−)-Carbodine] Against Venezuelan Equine Encephalitis Virus (VEEV) in a Mouse Model Antiviral Research. 74: A44-A45. DOI: 10.1016/J.Antiviral.2007.01.050 |
0.645 |
|
| 2006 |
Julander JG, Winger QA, Rickords LF, Shi PY, Tilgner M, Binduga-Gajewska I, Sidwell RW, Morrey JD. West Nile virus infection of the placenta. Virology. 347: 175-82. PMID 16406457 DOI: 10.1016/J.Virol.2005.11.040 |
0.662 |
|
| 2005 |
Day CW, Smee DF, Julander JG, Yamshchikov VF, Sidwell RW, Morrey JD. Error-prone replication of West Nile virus caused by ribavirin. Antiviral Research. 67: 38-45. PMID 15919121 DOI: 10.1016/J.Antiviral.2005.04.002 |
0.788 |
|
| 2005 |
Julander JG, Winger QA, Olsen AL, Day CW, Sidwell RW, Morrey JD. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. Antiviral Research. 65: 79-85. PMID 15708634 DOI: 10.1016/J.Antiviral.2004.10.005 |
0.813 |
|
| 2004 |
Morrey JD, Day CW, Julander JG, Olsen AL, Sidwell RW, Cheney CD, Blatt LM. Modeling hamsters for evaluating West Nile virus therapies. Antiviral Research. 63: 41-50. PMID 15196819 DOI: 10.1016/J.Antiviral.2004.02.005 |
0.806 |
|
| 2004 |
Morrey JD, Day CW, Julander JG, Blatt LM, Smee DF, Sidwell RW. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chemistry & Chemotherapy. 15: 101-9. PMID 15185728 DOI: 10.1177/095632020401500202 |
0.794 |
|
| 2004 |
Iyer RP, Roland A, Jin Y, Mounir S, Korba B, Julander JG, Morrey JD. Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model. Antimicrobial Agents and Chemotherapy. 48: 2318-20. PMID 15155244 DOI: 10.1128/Aac.48.6.2318-2320.2004 |
0.651 |
|
| 2003 |
Julander JG, Colonno RJ, Sidwell RW, Morrey JD. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Antiviral Research. 59: 155-61. PMID 12927305 DOI: 10.1016/S0166-3542(03)00109-8 |
0.667 |
|
| 2002 |
Julander JG, Sidwell RW, Morrey JD. Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Research. 55: 27-40. PMID 12076749 DOI: 10.1016/S0166-3542(01)00223-6 |
0.679 |
|
| Show low-probability matches. |